Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AOTILSE:AOTI +3.08%21 ROC (Joel Greenblatt) % is 41.35% as of Dec. 2025, which is 167% above its 10-year median of 15.50. GuruFocus rates LSE:AOTI with a GF Score™ of 21/100. The stock has 11 warning signs investors should review. Among 836 Medical Devices & Instruments companies, AOTI ranks better than 83.01% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. AOTI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 41.35%.
The historical rank and industry rank for AOTI's ROC (Joel Greenblatt) % or its related term are showing as below:
LSE:AOTI'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -193.93 Med: 15.5 Max: 249.11
Current: 37.75
During the past 5 years, AOTI's highest ROC (Joel Greenblatt) % was 249.11%. The lowest was -193.93%. And the median was 15.50%.
LSE:AOTI's ROC (Joel Greenblatt) % is ranked better than 83.01% of 836
companies
in the Medical Devices & Instruments industry
Industry Median: 4.86
vs LSE:AOTI: 37.75
AOTI's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for AOTI's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:AOTI vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, AOTI's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AOTI ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AOTI's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where AOTI's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 41.35% mean?
AOTI (LSE:AOTI) has a ROC (Joel Greenblatt) % of 41.35% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on AOTI and its competitors. This is 167% above median its historical median of 15.50. According to the industry distribution chart, AOTI ranks #142 out of 836 companies in the Medical Devices & Instruments industry, placing it in the top 17%.
Is AOTI's ROC (Joel Greenblatt) % too high?
AOTI's current ROC (Joel Greenblatt) % of 41.35% is 167% above median its 10-year median of 15.50. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.86. AOTI's value of 41.35% is 750.8% above this industry median. Based on the distribution chart, AOTI ranks #142 out of 836 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AOTI has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does AOTI's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AOTI ranks #142 out of 836 companies for ROC (Joel Greenblatt) %. This places AOTI in the top 17% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.86. AOTI's value of 41.35% is 750.8% above this benchmark. While the company's 10-year median is 15.50 vs. the industry median of 4.86, AOTI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.86, based on 836 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AOTI's current ROC (Joel Greenblatt) % of 41.35% is 750.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on AOTI and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AOTI's current ROC (Joel Greenblatt) % is 41.35%, which is 167% above median its own 10-year median of 15.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AOTI stock overvalued right now?
AOTI (LSE:AOTI) has a current ROC (Joel Greenblatt) % of 41.35%. The current ROC (Joel Greenblatt) % is 41.35%, which is 167% above median its 10-year median of 15.50 and 750.8% above the Medical Devices & Instruments industry median of 4.86. AOTI's overall GF Score™ is 21/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For AOTI (LSE:AOTI), the current ROC (Joel Greenblatt) % is 41.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AOTI Inc is the design, manufacture and provision of topical oxygen therapy products and services for healthcare providers and patients with chronic wounds. These products and services enable patients to heal faster and more durably and healthcare providers to reduce the overall cost of care. The specific purposes of the Company are to patent, manufacture, rent, and sell medical devices to help resolve severe acute and chronic wounds for customers globally. The Company operates in one reportable segment, which comprises the development and sale of Creative medical devices for therapeutic care. The company's solutions includes Multi-Modality Oxygen Therapy, Extremity Chamber, Multi-Patch, Negative Pressure Wound Therapy.
21GF Score
Get the complete analysis for LSE:AOTI
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:AOTI has been successfully added to your 
